In these studies, cognitively normal OSA+ participants progressed to MCI 6–18 months earlier than OSA- participants did, depending on their amyloid and tau burden (Osorio et al., 2015; Bubu et al., 2020). This evidence concerns the gene MAPT and obstructive sleep apnea syndrome.